Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Tellus You Care, a US-based telemedicine device supplier founded by Stanford University students, has obtained $2.8m in a round backed by university venture fund University of Tokyo Edge Capital and NTT Docomo Ventures, a corporate venturing arm of telecoms firm NTT Docomo, Forbes reported on Friday. The round also included internet group Digital Garage, startup studio AI Turtles and Miyako Capital, managers of Kyoto University’s second venture fund. Tellus You Care offers a radar-powered device that is mounted to the walls of elderly care homes to monitor movement and indications that a person may have collapsed. Tellus You Care is headquartered in San Francisco but also has a presence in Japan, where its product was launched in May 2020.
Susten Capital Management, a Japan-based operator of an investment mobile app, has raised ¥300m ($2.8m) from Tokyo University of Science Investment Management, the institution’s venture arm. The company had raised 730,000 in a seed round in January 2020 from undisclosed business companies and angel investors.
MabGenesis, a Japan-based biopharmaceutical technology spinout of University of Miyazaki and Fujita Health University, has raised ¥240m ($2.2m) from Nagoya University–Tokai Regionwide University Venture Fund, a joint investment venture formed by several Japanese universities and managed by VC firm Beyond Next Ventures. Construction firm Aoki Group’s Anniversaire Holdings subsidiary, financial services firms Miyazaki Bank and Sumitomo Mitsui Banking Corporation’s Miyagin Venture Capital and SMBC Venture Capital units filled out the round.
Beyond Next Ventures had already supported the company through its Brave Acceleration Program, which was followed by national innovation agency Japan Science and Technology Agency’s Start initiative. Beyond Next had also backed MabGenesis’s $340,000 seed round in December 2019.
University of Tokyo’s UTokyo IPC fund invested $1.4m in Tagcyx Biotechnologies, a Japan-based drug discovery platform developer, as part of a ¥200m ($1.9m) round earlier this month. The other participants in the round have not been disclosed but it follows $4.8m from insurer Nippon Life’s Nissay Capital unit, financial services firm Sumitomo Mitsui Banking Corporation’s SMBC Venture Capital vehicle and University of Tokyo Edge Capital (UTEC) in 2016, and $4.6m from SMBC Venture Capital, UTEC and Mizuho Capital in April 2018. [this news item first appeared on our sister site, Global Corporate Venturing]
Core Life Analytics, a Netherlands-based biological data analysis spinout of University Medical Center Utrecht, has secured €1m ($1.1m) in a round featuring Utrecht Holdings, the tech transfer company for both the medical centre and Utrecht University. The round was filled out by Bom Brabant Ventures, the venture arm of Dutch state-owned regional development agency Brabantse Ontwikkelings Maatschappij, in addition to investment fund TechFund One. Core Life Analytics uses artificial intelligence to process complex datasets for developing new medicines. Clients using the technology include pharmaceutical firm Pfizer, Galapagos and Janssen, part of healthcare products group Johnson & Johnson. The additional funding will be put toward Core Life’s product development.
Diagnotes, a US-based healthcare records and communication platform spun out of Indiana University (IU), has received $500,000 from the university through its Philanthropic Venture Fund and Innovate Indiana Fund. Founded in 2010, Diagnotes provides cloud software that enables care providers to schedule appointments access patient health records and communicate via either text, voice or video. It will use the funding to recruit a chief commercial officer and additional sales personnel while also extending its marketing output. The spinout’s co-founders include Todd Saxton, associate professor of strategy and entrepreneurship in the Kelley School of Business, part of Indiana University – Purdue University Indianapolis. IU Philanthropic Venture Fund previously supplied $500,000 to Diagnotes in January 2019, following around $1.8m of equity, debt and securities raised in 2017 and 2018, according to regulatory filings. Diagnotes’ other investors include university matching fund Purdue Ventures and Indiana Seed Fund, whose LPs include IU and University of Notre Dame.
Freecracy, the Japan-based operator of business networking app FreeC, has raised an undisclosed amount of funding from Persol Asia Pacific, which is a brand under PersoKelly, a joint venture between recruitment firms Persol Holdings and Kelly Services. Freecracy and Persol Asia Pacific will ink a strategic partnership and jointly accelerate research and development efforts for artificial intelligence-based recruitment, and expand its platform’s presence in Southeast Asia. Freecracy previously raised $470,000 in May 2019 from marketing technology provider Voyage’s corporate venturing subsidiary, Voyage Ventures, and Assertive Investment, having already secured $140,000 in 2018 from Digital Hollywood, which operates Digital Hollywood University, and assorted angel investors.
– Additional reporting by Liwen-Edison Fu and Robert Lavine


